The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

Share Price Information for Clean Power Hyd (CPH2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.167%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
CPH2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreements Signed with Fabrum Solutions Ltd

22 Dec 2022 07:00

RNS Number : 5423K
Clean Power Hydrogen
22 December 2022
 

 

 

22 December 2022

 

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

 

Development Agreement and Extension of Supply Agreement signed with New Zealand based Fabrum Solutions Ltd

 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that it has executed a development agreement with New Zealand based Fabrum Solutions Ltd ("Fabrum") (the "Development Agreement"), one of the world's leading cryogenic systems manufacturers for gas separation and hydrogen liquefaction. Fabrum is the result of the merger between Fabrum Solutions and AFCryo, the Company's supplier of the cryogenic systems since 2020.

 

Development Agreement

The Development Agreement has been executed for the purposes of the technical development of the Company's MFE. Under the terms of the Development Agreement Fabrum will work with CPH2, and its existing industry partner Kenera Energy Solutions ("Kenera"), to provide engineering expertise in support of design reviews, systems documentation and safety cases.

Fabrum will further provide technical support to accelerate the final development of the CPH2 technology, including subsystem development of the cryogenic gas separation and full system development. This development support will be focused on the safe and efficient operation of the cryogenic gas separation system at a 1MW scale and at the expanded operation level up to a nominal 2MW scale.

Finally, whilst CPH2 undertakes the process of identifying and appointing a Chief Technical Officer, Fabrum will supply CPH2 with the expertise of their current Technical Director, Hugh Reynolds, who will assist on a part-time basis in the role of Acting Chief Technical Officer for CPH2.

The Development Agreement compliments the existing arrangements with Kenera. Following the execution of the Development Agreement the teams at CPH2, Fabrum and Kenera will work alongside each other to accelerate the development and production of the MFE220 units.

Supply Agreement

In addition, the Company has executed a deed of variation to its existing supply agreement with Fabrum to allow it to purchase DPWG Cryocoolers for embedding in its MFE products on an exclusive basis. The excusive supply agreement is subject to various minimum order quantities being met in each year of its initial five year term from the date of execution. Under the terms of the revised supply agreement, Fabrum is also required to meet performance and price criteria.

The revised supply agreement with Fabrum strengthens the Company's supply chain security over a key component of the MFE as well as enhancing the commercial alignment between Fabrum and CPH2.

 

Jon Duffy, Chief Executive Officer of CPH2, commented:

 

"I am delighted we are deepening our working relationship with Fabrum, the world leaders in cryogenic systems and hydrogen liquefaction. The collaboration between CPH2, Fabrum and Kenera, a global provider of innovative customer-centric solutions, will ensure that we can utilise the broad expertise of all parties in the production of the MFE220. The agreements with Fabrum will lead to an acceleration to market of our MFE electrolysers and we look forward to working with Hugh Reynolds and his team and collaborating to benefit all parties."

 

 

For more information, please contact:

 

Clean Power Hydrogen Plc

via Camarco

Jon Duffy, Chief Executive Officer

Cenkos Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Billy Clegg

Owen Roberts

Fergus Young

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFEFESFEESEIE
12
Date   Source Headline
19th Apr 20247:00 amRNS2023 Full Year Results
23rd Feb 20247:00 amRNSAwards under Long-Term Incentive Plan
21st Feb 20247:00 amRNSOperational Update
5th Feb 20247:00 amRNSISO Certifications
28th Nov 20237:00 amRNSRevised Agreement with ATOME Energy
20th Nov 20237:00 amRNSChange of Nominated Adviser
2nd Nov 20237:00 amRNSCompany Update
21st Sep 20237:00 amRNSInterim Results
22nd Jun 20237:00 amRNS2023 Save As You Earn Scheme
21st Jun 20231:09 pmRNSResult of AGM
19th Jun 20237:00 amRNSGrant of EMI Options
6th Jun 20237:00 amRNSUpdate on Licence Agreement with GHFG Limited
17th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
28th Apr 202312:16 pmRNSHoldings in Company
26th Apr 20233:26 pmRNSPDMR Dealing
25th Apr 20237:00 amRNSCorporate Presentation
20th Apr 20237:00 amRNSMaiden Financial Results
13th Apr 20237:00 amRNSInvestor Presentation
27th Mar 20237:00 amRNSFabrum Solutions Ltd receives order from Obayashi
16th Mar 20237:00 amRNSPDMR Dealing
27th Feb 20237:00 amRNSLock-in Agreement Extension
8th Feb 20237:00 amRNSSave As You Earn Scheme
31st Jan 20237:00 amRNSManufacturing Agreement with Fabrum Solutions Ltd
26th Jan 20237:00 amRNSAppointment of Chief Technical Officer
22nd Dec 20227:00 amRNSAgreements Signed with Fabrum Solutions Ltd
20th Dec 20221:14 pmRNSHolding(s) in Company
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.